title: Enhancement of endothelium-dependent flow-mediated vasodilation in hyperthyroidism.
abstract: OBJECTIVE
  Vascular responsiveness changes in hyperthyroid patients remains controversial. This study attempts to determine whether the vasomotor activity can be influenced by hyperthyroid conditions, and, if so, whether changes induced by hyperthyroidism may be restored to normal during the euthyroid state after treatment.
  
  
  METHODS
  A case-control clinical study.
  
  
  METHODS
  Forty-five pretreated hyperthyroid patients (mean age 36.62 +/- 10.12 years, 36 female) were compared with 45 gender- and age-matched control subjects (mean age 38.98 +/- 11.17 years, 40 female). Brachial artery endothelium-dependent flow-mediated vasodilation (FMD) and endothelium-independent nitroglycerin-mediated vasodilation (NMD) responses were assessed noninvasively by high-resolution ultrasound imaging. Among the 45 hyperthyroid patients, 27 patients underwent the same procedures prospectively in the post-treatment euthyroid state.
  
  
  RESULTS
  The FMD values were significantly increased in hyperthyroid patients vs. those of controls (8.94 +/- 5.65%vs. 3.77 +/- 3.42%, P < 0.001), whereas NMD levels were not significantly different (18.17 +/- 7.76%vs. 17.28 +/- 6.63%, P = 0.560). Multiple regression analysis revealed that the presence of hyperthyroidism was the only significant factor associated with FMD. In the follow-up study of 27 hyperthyroid patients, the FMD values were significantly decreased in the post-treatment euthyroid state compared with those in the pretreated hyperthyroid state (6.40 +/- 4.27%vs. 8.83 +/- 4.61%, P = 0.021), although these values were still higher than those of controls.
  
  
  CONCLUSIONS
  This study demonstrated that endothelium-dependent FMD was increased in the hyperthyroid patients, and could be partially restored by treatment with antithyroid agents.
authors.affiliation: First Cardiovascular Division, Department of Cardiology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Tao-yuan, Taiwan.
authors.forename: Wan-Jing
authors.initials: WJ
authors.lastname: Ho
authors.forename: Szu-Tah
authors.initials: ST
authors.lastname: Chen
authors.forename: Pei-Kwei
authors.initials: PK
authors.lastname: Tsay
authors.forename: Chun-Li
authors.initials: CL
authors.lastname: Wang
authors.forename: Tsu-Shiu
authors.initials: TS
authors.lastname: Hsu
authors.forename: Chi-Tai
authors.initials: CT
authors.lastname: Kuo
authors.forename: Wei-Jan
authors.initials: WJ
authors.lastname: Chen
mesh_terms: D000328:Adult; D013956:Antithyroid Agents / Q000627:therapeutic use; D001916:Brachial Artery / Q000000981:diagnostic imaging; D016022:Case-Control Studies; D004730:Endothelium, Vascular / Q000187:drug effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy / Q000503:physiopathology*; D008713:Methimazole / Q000627:therapeutic use; D008875:Middle Aged; D005996:Nitroglycerin; D011441:Propylthiouracil / Q000627:therapeutic use; D011446:Prospective Studies; D012039:Regional Blood Flow / Q000187:drug effects; D012044:Regression Analysis; D014463:Ultrasonography; D014664:Vasodilation / Q000502:physiology*; D014665:Vasodilator Agents
chemical_list: D013956:Antithyroid Agents; D014665:Vasodilator Agents; D008713:Methimazole; D011441:Propylthiouracil; D005996:Nitroglycerin